Supriya Lifescience Limited (BOM:543434)
728.15
+3.95 (0.55%)
At close: Jul 2, 2025
Supriya Lifescience Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Cash & Equivalents | 791.54 | 683.49 | 852.51 | 1,658 | 434.98 | Upgrade
|
Short-Term Investments | - | 45.69 | 723.31 | 591.55 | 429.28 | Upgrade
|
Cash & Short-Term Investments | 791.54 | 729.18 | 1,576 | 2,249 | 864.26 | Upgrade
|
Cash Growth | 8.55% | -53.73% | -29.94% | 160.26% | 20.28% | Upgrade
|
Accounts Receivable | 1,344 | 1,117 | 846.64 | 1,152 | 735 | Upgrade
|
Other Receivables | 7.11 | 45.09 | 64.06 | 60.32 | 30.16 | Upgrade
|
Receivables | 1,360 | 1,169 | 916.16 | 1,218 | 770.44 | Upgrade
|
Inventory | 1,183 | 852.49 | 1,158 | 923.12 | 724.8 | Upgrade
|
Prepaid Expenses | - | 112.25 | 108.48 | 72.45 | 9.98 | Upgrade
|
Other Current Assets | 1,035 | 1,115 | 890.71 | 512.77 | 285.15 | Upgrade
|
Total Current Assets | 4,370 | 3,978 | 4,649 | 4,975 | 2,655 | Upgrade
|
Property, Plant & Equipment | 5,995 | 4,573 | 3,281 | 2,317 | 1,772 | Upgrade
|
Long-Term Investments | 632.41 | 637.95 | 252.96 | 0.53 | 0.53 | Upgrade
|
Other Intangible Assets | 13.89 | 16.56 | 11.06 | 15.09 | 16.13 | Upgrade
|
Other Long-Term Assets | 111.54 | 6.82 | 9.28 | 39.82 | 11.24 | Upgrade
|
Total Assets | 11,123 | 9,212 | 8,203 | 7,348 | 4,455 | Upgrade
|
Accounts Payable | 745.46 | 595.69 | 642.28 | 489.72 | 510.22 | Upgrade
|
Accrued Expenses | 11.93 | 33.26 | 27.58 | 29.58 | 34.87 | Upgrade
|
Short-Term Debt | - | - | 166.25 | 212.95 | 674.11 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 27.19 | Upgrade
|
Current Portion of Leases | 3.23 | 4.68 | 3.54 | 8.25 | - | Upgrade
|
Current Income Taxes Payable | - | -26.8 | 45.87 | 64.11 | 152 | Upgrade
|
Other Current Liabilities | 61 | 162.11 | 72.28 | 192.38 | 61.8 | Upgrade
|
Total Current Liabilities | 821.62 | 768.94 | 957.8 | 996.99 | 1,460 | Upgrade
|
Long-Term Leases | 50.57 | 50.2 | 54.89 | 52.95 | 20.65 | Upgrade
|
Long-Term Deferred Tax Liabilities | 270.18 | 231.52 | 136.75 | 111.49 | 80.11 | Upgrade
|
Other Long-Term Liabilities | 13.17 | 8.05 | 11.45 | 2.59 | 194.87 | Upgrade
|
Total Liabilities | 1,156 | 1,059 | 1,208 | 1,191 | 1,769 | Upgrade
|
Common Stock | 160.97 | 160.97 | 160.97 | 160.97 | 146.37 | Upgrade
|
Additional Paid-In Capital | - | 1,985 | 1,985 | 1,985 | - | Upgrade
|
Retained Earnings | - | 6,004 | 4,862 | 4,011 | 2,539 | Upgrade
|
Comprehensive Income & Other | 9,807 | 2.81 | -13.42 | -0.01 | - | Upgrade
|
Shareholders' Equity | 9,968 | 8,154 | 6,995 | 6,157 | 2,686 | Upgrade
|
Total Liabilities & Equity | 11,123 | 9,212 | 8,203 | 7,348 | 4,455 | Upgrade
|
Total Debt | 53.8 | 54.88 | 224.68 | 274.15 | 721.95 | Upgrade
|
Net Cash (Debt) | 737.74 | 674.3 | 1,351 | 1,975 | 142.31 | Upgrade
|
Net Cash Growth | 9.41% | -50.09% | -31.59% | 1287.90% | - | Upgrade
|
Net Cash Per Share | 9.16 | 8.38 | 16.79 | 24.54 | 1.94 | Upgrade
|
Filing Date Shares Outstanding | 80.1 | 80.48 | 80.48 | 80.48 | 73.18 | Upgrade
|
Total Common Shares Outstanding | 80.1 | 80.48 | 80.48 | 80.48 | 73.18 | Upgrade
|
Working Capital | 3,549 | 3,209 | 3,691 | 3,978 | 1,194 | Upgrade
|
Book Value Per Share | 124.44 | 101.31 | 86.91 | 76.50 | 36.70 | Upgrade
|
Tangible Book Value | 9,954 | 8,137 | 6,984 | 6,142 | 2,670 | Upgrade
|
Tangible Book Value Per Share | 124.27 | 101.10 | 86.77 | 76.31 | 36.48 | Upgrade
|
Land | - | 104.16 | 91.64 | 91.6 | 77.86 | Upgrade
|
Buildings | - | 857.69 | 724.16 | 546.76 | 282.98 | Upgrade
|
Machinery | - | 2,621 | 2,132 | 1,474 | 803.6 | Upgrade
|
Construction In Progress | - | 1,488 | 676.28 | 434.09 | 787.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.